Skip to main content

Advertisement

Log in

Prophylaxis for travelers’ diarrhea

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Travelers’ diarrhea affects more than 10 million people per year and is usually contracted through the ingestion of microbially contaminated food or water. Although most cases resolve in 3 to 5 days, chronic conditions are associated with acute infections. Prevention encompasses avoidance of ingesting contaminated products and, in certain situations, taking prophylactic medications. The available prophylactic antibiotics are very effective in prevention, but are recommended only for specific at-risk individuals and are contraindicated for most travelers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Steffen R: Epidemiologic studies of travelers’ diarrhea, severe gastrointestinal infections, and cholera, Rev Infect Dis 1986, 8(Suppl 2):S122–S130.

    PubMed  Google Scholar 

  2. Rees JR, Pannier MA, McNees A, et al.: Persistent diarrhea, arthritis, and other complications of enteric infections: a pilot survey based on California FoodNet surveillance, 1998–1999. Clin Infect Dis 2004, 38(Suppl 3):S311–S317.

    Article  PubMed  Google Scholar 

  3. Sharp TW, Thornton SA, Wallace MR, et al.: Diarrheal disease among military personnel during Operation Restore Hope, Somalia, 1992–1993. Am J Trop Med Hyg 1995, 52:188–193.

    PubMed  CAS  Google Scholar 

  4. Taylor DN, Rizzo J, Meza R, et al.: Cholera among Americans living in Peru. Clin Infect Dis 1996, 22:1108–1109.

    PubMed  CAS  Google Scholar 

  5. von Sonnenburg F, Tornieporth N, Waiyaki P, et al.: Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000, 356:133–134.

    Article  Google Scholar 

  6. Shlim DR: Update in travelers’ diarrhea. Infect Dis Clin North Am 2005, 19:137–149.

    Article  PubMed  Google Scholar 

  7. Widdowson M, Monroe SS, Glass RI: Are noroviruses emerging? Emerg Infect Dis 2005, 11:735–737.

    PubMed  Google Scholar 

  8. Huang DB, Sanchez AP, Triana E, et al.: United States male students who heavily consume alcohol in Mexico are at greater risk of travelers’ diarrhea than their female counterparts. J Travel Med 2004, 11:143–145.

    PubMed  Google Scholar 

  9. Kozicki M, Steffen R, Schär M: ’Boil it, cook it, peel it or forget it’: does this rule prevent travellers’ diarrhoea? Int J Epidemiol 1985, 14:169–172.

    Article  PubMed  CAS  Google Scholar 

  10. Hill DR, Ericsson CD, Pearson RD, et al.: The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1499–1539.

    Article  PubMed  CAS  Google Scholar 

  11. Steffen R: Epidemiology of travelers’ diarrhea. Clin Infect Dis 2006, 41(Suppl 8):S536–S540.

    Google Scholar 

  12. Frech SA, Dupont HL, Bourgeois AL, et al.: Use of patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomized, double-blind, placebo-controlled field trial. Lancet 2008, 371:2019.

    Article  PubMed  CAS  Google Scholar 

  13. DuPont HL, Sullivan P, Evans DG, et al.: Prevention of travelers’ diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth. JAMA 1980, 243:237–241.

    Article  PubMed  CAS  Google Scholar 

  14. Dupont HL, Ericsson CD, Johnson PC, et al.: Prevention of travelers’ diarrhea by the tablet formulation of bismuth subsalicylate. Antimicrob Agents Chemother 1986, 29:625–627.

    PubMed  Google Scholar 

  15. Taylor DN, Sanchez JL, Candler W, et al.: Treatment of travelers’ diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med 1991, 114:731–734.

    PubMed  CAS  Google Scholar 

  16. Sack RB, Santosham M, Froelich JL, et al.: Doxycyline prophylaxis of travelers’ diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli. Am J Trop Med Hyg 1984, 33:460–466.

    PubMed  CAS  Google Scholar 

  17. Rademaker CMA, Hoepleman IM, Wolfhagen HM, et al.: Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers’ diarrhea. Eur J Clin Microbiol Infect Dis 1989, 8:690–694.

    Article  PubMed  CAS  Google Scholar 

  18. Dupont H, Jiang ZD, Okhuysen PC, et al.: A randomized, double-blind, placebo-controlled trial of azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 2003, 37:1165–1171.

    Article  PubMed  Google Scholar 

  19. DuPont HL, Jiang ZD, Okhuysen PC, et al.: A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers’ diarrhea. Ann Intern Med 2005, 142:805–812.

    PubMed  CAS  Google Scholar 

  20. McFarland LV: Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis 2007, 5:97–105.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emily Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, E., Redfield, D. Prophylaxis for travelers’ diarrhea. Curr Gastroenterol Rep 11, 297–300 (2009). https://doi.org/10.1007/s11894-009-0043-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-009-0043-1

Keywords

Navigation